Summary

A phase II single-blind, randomized, placebo-controlled trial to study the efficacy and safety of Study Drug administered as adjunctive treatment to patients with acquired thrombotic thrombocytopenic purpura.

Register to download

PRA Successfully Rescues Phase II Hematology Study

You may also be interested in: